ER

Ernexa Therapeutics Inc. Warrants

ERNA ·

Ernexa Therapeutics Inc. Warrants (ERNA) is a Asset management company in the Financial services sector, listed on Nasdaq. This page provides the complete earnings calendar, dividend schedule, and financial data for Ernexa Therapeutics Inc. Warrants in 2026. The next earnings report is expected on November 11, 2026.

Earnings calendar

Next earnings date

11 Nov 2026

In 81 days

EPS estimate

-3.84

Revenue estimate

—

Past earnings

06 Aug 2026
EPS actual
—
estimate -3.30
Revenue actual
—
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
11 May 2026
EPS actual
-6.95 (-256.4%)
estimate -1.95
Revenue actual
—
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
Beat Miss usd

Latest earnings analysis

Ernexa Therapeutics Inc. Warrants missed consensus estimates in its latest earnings report, with EPS of $-6.95 versus an expected $-1.95, and revenue was not disclosed. No prior report is available for comparison.

Dividend calendar

No dividend history available.

EPS (Earnings Per Share)

Revenue

Company profile

Ernexa Therapeutics Inc., a preclinical-stage company, develops induces derived mesenchymal stem cells (iMSC) therapies for the treatment of solid tumors and autoimmune disease. The company's lead product is ERNA-101, an allogenic pro-inflammatory cytokine (IL-7/IL-15) secreting iMSC for the treatment of ovarian cancer; and ERNA-102, an anti-inflammatory cytokine (IL-10) secreting iMSC for the treatment of rheumatoid arthritis. It has a license agreement with Factor Bioscience Limited. The company was formerly known as Eterna Therapeutics Inc. and changed its name to Ernexa Therapeutics in March 2025. Ernexa Therapeutics Inc. was founded in 2018 and is based in Cambridge, Massachusetts.

Sector
Financial services
Industry
Asset management
Country
United States
Exchange
Nasdaq
CEO
Sanjeev Luther
Employees
6
IPO date
12 Jul 2024
ISIN
US1140823089
Website
ernexatx.com

Frequently asked questions

When does Ernexa Therapeutics Inc. Warrants (ERNA) next report earnings?

Ernexa Therapeutics Inc. Warrants (ERNA) is scheduled to report earnings on November 11, 2026.

What was Ernexa Therapeutics Inc. Warrants's most recent earnings date?

Ernexa Therapeutics Inc. Warrants (ERNA) last reported earnings on August 6, 2026.

Where is Ernexa Therapeutics Inc. Warrants stock listed?

Ernexa Therapeutics Inc. Warrants (ERNA) is listed on Nasdaq.